A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Background: Small-cell lung cancer (SCLC), a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9–11 months for patients with extensive stage (EX-SCLC...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2014
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://ncbi.nlm.nih.gov/pubmed/25353007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00271
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia